Company profile
Response Genetics, Inc
OTC: RGDXQ · Healthcare · Medical - Diagnostics & Research
#567 of 1,422 Healthcare companies by revenue53rd-percentile growth
EA Score
——FH —DQ —GM —SS 48
v0.1 · 5/100 weight · pillars only
↑ growth stability, listing tenure · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$16.6M
Rev growth YoY (TTM)
-8.1%
Net income (FY)
-$20.2M
Employees
96
as of 2026-08-30
Market cap
$3.9k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.0M$18.0M2015
Net income-$20.2M-$20.2M2015
Operating income-$21.4M-$21.4M2015
Total assets$48.9M$48.9M2015
Liabilities$15.9M$15.9M2015
Equity$33.0M$33.0M2015
Revenue trend
FY2008 – FY2015 · USD
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Response Genetics, Inc’s revenue?
Response Genetics, Inc booked $18.0M in FY2015 revenue, growing 7.9% year over year — about the middle of the pack among Healthcare companies we track, at a -111.9% net margin.
Peers · Healthcare
Avicanna Inc.55CTrees Corporation——Marpai, Inc.34DManifestSeven Holdings Corporation——Vibe Growth Corporation58CMicron Solutions, Inc.——Neighbors
Los Angeles →Key facts
CEOThomas Bologna
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersLos Angeles, CA
ExchangeOTC: RGDXQ
Employees96
IPO date2007-06-05
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.